In ELISA for detecting anti-HCV antibodies, a patient sample is tested using a 4th generation assay (combined antigen-antibody ELISA). The sensitivity window for anti-HCV detection (compared to HCV RNA NAAT) is approximately:

• A Anti-HCV antibodies appear 8–12 weeks after infection (seronegative window period); HCV RNA is detectable within 1–2 weeks of infection ✓
• B Anti-HCV antibodies appear within 1 week of HCV RNA positivity — no clinically significant window period
• C Anti-HCV antibodies and HCV RNA become detectable simultaneously at 4 weeks post-exposure
• D 4th generation HCV ELISAs detect HCV core antigen with sensitivity equal to RNA PCR within 7 days of exposure

Explanation

HCV RNA by NAAT is detectable within 1–2 weeks of exposure (even within 3–5 days in some studies), long before any antibody response. Anti-HCV IgG antibodies (detected by 3rd/4th generation ELISAs using recombinant HCV proteins from Core, NS3, NS4, NS5 regions) typically appear 8–12 weeks post-exposure. This creates an important diagnostic window — patients with acute HCV will be ELISA-negative but RNA-positive. In immunosuppressed patients (HIV co-infection, organ transplant recipients), anti-HCV seroconversion may be delayed further or fail entirely. Therefore, HCV RNA PCR is required for: suspected acute HCV, immunosuppressed patients, and for confirmation of active infection (anti-HCV can remain positive after clearance). Core antigen assay reduces the window to ~3 weeks.

Reference: Ananthanarayan & Paniker's Textbook of Microbiology, 11th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.